EZH2-Activating Mutations in DLBCL Are Easily Predictable by Routine Immunohistochemistry Analysis: a Tool to More Efficiently Define EZH2 Inhibitor-Sensitive Patients?
Titel:
EZH2-Activating Mutations in DLBCL Are Easily Predictable by Routine Immunohistochemistry Analysis: a Tool to More Efficiently Define EZH2 Inhibitor-Sensitive Patients?
Auteur:
Dubois, Sydney Mareschal, Sylvain Cornic, Marie Picquenot, Jean-Michel Bohers, Elodie Alcantara, Marion Maingonnat, Catherine Bertrand, Philippe Ruminy, Philippe Bastard, Christian Tilly, Herve Jardin, Fabrice